SCHEMBL9708893

SCHEMBL9708893

CCc1nc2c(c(=O)n(CC3CC3)c(=O)n2CCOC)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 8/20 0.44
PDE4A P27815 8/20 0.44
PDE4B Q07343 8/20 0.44
PDE4C Q08493 8/20 0.44
PDE4D Q08499 8/20 0.44
ADORA3 P0DMS8 8/20 0.42
AGTR1 P30556 2/20 0.40
AGTR2 P50052 2/20 0.40
ADORA2A P29274 1/20 0.40
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708807 0.98 PDE5A (0.43) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL9707920 0.94 AGTR1 (0.43) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL9708071 0.93 PDE5A (0.49) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL9708085 0.93 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9708127 0.92 AGTR1 (0.46) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL9707532 0.92 AGTR1 (0.42) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL9708006 0.92 PDE5A (0.46) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL9707274 0.91 PDE5A (0.45) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL9707830 0.91 AGTR1 (0.41) ADORA3AGTR1AGTR2ADORA2A
SCHEMBL9707865 0.91 AGTR1 (0.48) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed